Connect Biopharma Holdings (CNTB) Exchange Rate Effect (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Exchange Rate Effect of $72000.0 for Q1 2026, down 4.0% year-on-year from $75000.0 in Q1 2025, and up 41.18% on a QoQ basis from $51000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Exchange Rate Effect for 3 consecutive years, with $72000.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 4.0% year-over-year to $72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $405000.0 (up 235.45% YoY) and the FY2025 annual result came in at $408000.0, up 168.57% from the prior year.
- Exchange Rate Effect improved to $72000.0 in Q1 2026 per CNTB's latest filing, from $51000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for CNTB reached as high as $507000.0 in Q3 2024 and fell as low as -$983000.0 in Q4 2024.
- A 3-year average of -$12777.8 and a median of $72000.0 in 2026 frame the typical range for Exchange Rate Effect.
- The largest YoY upside for Exchange Rate Effect was 133.94% in 2025 against a maximum downside of 88.56% in 2025.
- Year by year, Exchange Rate Effect stood at -$983000.0 in 2024, then surged by 105.19% to $51000.0 in 2025, then soared by 41.18% to $72000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $72000.0, $51000.0, and $58000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Mar 31, 2024 | -221,000.00 |
| Mar 31, 2024 | -221,000.00 |